papers

Differential List

Row Disease Sample Type Official Symbol Sign Of Difference Experimental Design Control Case P Value Paper Link Type Of Study Organism Variable Name Variable Category Case Count Control Count Technique Confidence Interval
213 Acute Sulfur Mustard Exposure NM ATP DOWN Case-Control Untreated cells Acute Sulfur Mustard Exposure <0.05 in vivo Bos taurus ATP level Metabolite 4 4 Luciferin/luciferase assay NM
214 Acute Sulfur Mustard Exposure NM NAD+ DOWN Case-Control Untreated cells Acute Sulfur Mustard Exposure <0.05 in vivo Rattus norvegicus NAD+ Metabolite 5 5 Spectrophotometry NM
229 Acute Sulfur Mustard Exposure NM NAD+ DOWN Case-Control Untreated cells Acute Sulfur Mustard Exposure <0.05 in vivo Rattus norvegicus NAD+ Metabolite 7 7 Spectrophotometry NM
392 Acute Sulfur Mustard Exposure Blood erythrocyte UP Case-Control Healthy Control Acute Sulfur Mustard Exposure <0.01 in vivo Sus scrofa Red blood cell Cell 8 12 Cell counting NM
583 Acute Sulfur Mustard Exposure Blood erythrocyte DOWN Case-Control Healthy Control Acute Sulfur Mustard Exposure <0.05 in vivo Sus scrofa Red blood cell Cell 8 12 Cell counting NM
584 Acute Sulfur Mustard Exposure Bronchoalveolar Lavage (BAL) neutrophil DOWN Case-Control Healthy Control Acute Sulfur Mustard Exposure <0.05 in vivo Sus scrofa white blood cell Cell 8 12 Cell counting NM
585 Acute Sulfur Mustard Exposure Blood bicarbonate DOWN Case-Control Healthy Control Acute Sulfur Mustard Exposure <0.01 in vivo Sus scrofa n arterial blood bicarbonate concentration Metabolite 8 12 Gas analyzer NM
586 Acute Sulfur Mustard Exposure Blood bicarbonate UP Case-Control Healthy Control Acute Sulfur Mustard Exposure <0.05 in vivo Sus scrofa n arterial blood bicarbonate concentration Metabolite 8 12 Gas analyzer NM
668 Acute Sulfur Mustard Exposure Lung Biopsy thiol concentration UP Case-Control Healthy Control Acute Sulfur Mustard Exposure <0.05 in vivo Sus scrofa Total lung tissue thiol concentrations Metabolite 8 12 Enzyme-linked immunosorbent assay (ELISA) NM
669 Acute Sulfur Mustard Exposure Urine desmosine UP Case-Control Healthy Control Acute Sulfur Mustard Exposure <0.05 in vivo Sus scrofa Urinary desmosine Metabolite 8 12 Enzyme-linked immunosorbent assay (ELISA) NM
671 Acute Sulfur Mustard Exposure Blood arterial carbon dioxide partial pressure (PaCO2) DOWN Case-Control Healthy Control Acute Sulfur Mustard Exposure <0.05 in vivo Sus scrofa carbon dioxide and reduced hemoglobin levels Phenotype 8 12 Gas analyzer NM
765 Acute Sulfur Mustard Exposure Blood arterial oxygen partial pressure (PaO2) DOWN Case-Control Healthy Control Acute Sulfur Mustard Exposure <0.001 in vivo Sus scrofa Arterial blood oxygenation Phenotype 8 12 Gas analyzer NM
766 Acute Sulfur Mustard Exposure Blood arterial oxygen partial pressure (PaO2) UP Case-Control Healthy Control Acute Sulfur Mustard Exposure <0.05 in vivo Sus scrofa carbon dioxide and reduced hemoglobin levels Phenotype 8 12 Gas analyzer NM
767 Acute Sulfur Mustard Exposure Blood heart rate UP Case-Control Healthy Control Acute Sulfur Mustard Exposure <0.05 in vivo Sus scrofa heart rate Phenotype 8 12 Gas analyzer NM
768 Acute Sulfur Mustard Exposure Blood heart rate UP Case-Control Healthy Control Acute Sulfur Mustard Exposure <0.05 in vivo Sus scrofa heart rate Phenotype 8 12 Gas analyzer NM
769 Acute Sulfur Mustard Exposure Blood shunt fraction (Qs/Qt) DOWN Case-Control Healthy Control Acute Sulfur Mustard Exposure <0.05 in vivo Sus scrofa shunt fraction Qs/Qt Phenotype 8 12 Gas analyzer NM
770 Acute Sulfur Mustard Exposure Blood heart rate UP Case-Control Healthy Control Acute Sulfur Mustard Exposure <0.01 in vivo Sus scrofa heart rate Phenotype 8 12 Gas analyzer NM
771 Acute Sulfur Mustard Exposure Blood shunt fraction (Qs/Qt) UP Case-Control Healthy Control Acute Sulfur Mustard Exposure <0.001 in vivo Sus scrofa shunt fraction Qs/Qt Phenotype 8 12 Gas analyzer NM
772 Acute Sulfur Mustard Exposure Bronchoalveolar Lavage (BAL) total protein level DOWN Case-Control Healthy Control Acute Sulfur Mustard Exposure <0.05 in vivo Sus scrofa The amount of protein Protein 8 12 Enzyme-linked immunosorbent assay (ELISA) NM
773 CEES Exposure Lung Biopsy ATF2 UP Case-Control Healthy Control CEES Exposure <0.05 in vivo Cavia porcellus Effects of antioxidant liposome on CEES-mediated activation of ATF-2 transcription factors Protein 3 3 Western blot analysis NM
774 CEES Exposure Lung Biopsy ATF2 UP Case-Control CEES Exposure CEES Exposure <0.05 in vivo Cavia porcellus Effects of antioxidant liposome on CEES-mediated activation of ATF-2 transcription factors Protein 3 3 Western blot analysis NM
775 CEES Exposure Lung Biopsy ATF2 UP Case-Control Healthy Control CEES Exposure <0.05 in vivo Cavia porcellus Effects of antioxidant liposome on CEES-mediated activation of ATF-2 transcription factors Protein 3 3 Western blot analysis NM
776 CEES Exposure Lung Biopsy ATF2 DOWN Case-Control CEES Exposure CEES Exposure <0.05 in vivo Cavia porcellus Effects of antioxidant liposome on CEES-mediated activation of ATF-2 transcription factors Protein 3 3 Western blot analysis NM
777 CEES Exposure Lung Biopsy FOS UP Case-Control Healthy Control CEES Exposure <0.05 in vivo Cavia porcellus DNA Binding Activity of AP-1 family Protein 3 3 Enzyme-linked immunosorbent assay (ELISA) NM
778 CEES Exposure Lung Biopsy FOS DOWN Case-Control CEES Exposure CEES Exposure <0.05 in vivo Cavia porcellus DNA Binding Activity of AP-1 family Protein 3 3 Enzyme-linked immunosorbent assay (ELISA) NM
779 CEES Exposure Lung Biopsy FOS UP Case-Control Healthy Control CEES Exposure <0.05 in vivo Cavia porcellus DNA Binding Activity of AP-1 family Protein 3 3 Enzyme-linked immunosorbent assay (ELISA) NM
780 CEES Exposure Lung Biopsy FOS DOWN Case-Control CEES Exposure CEES Exposure <0.05 in vivo Cavia porcellus DNA Binding Activity of AP-1 family Protein 3 3 Enzyme-linked immunosorbent assay (ELISA) NM
781 CEES Exposure Lung Biopsy FOS UP Case-Control Healthy Control CEES Exposure <0.05 in vivo Cavia porcellus Inhibition of CEES-induced increase in protein levels of AP-1 transcription factors by antioxidant liposome Protein 3 3 Western blot analysis NM
782 CEES Exposure Lung Biopsy FOS UP Case-Control CEES Exposure CEES Exposure <0.05 in vivo Cavia porcellus Inhibition of CEES-induced increase in protein levels of AP-1 transcription factors by antioxidant liposome Protein 3 3 Western blot analysis NM
783 CEES Exposure Lung Biopsy FOS UP Case-Control Healthy Control CEES Exposure <0.05 in vivo Cavia porcellus Inhibition of CEES-induced increase in protein levels of AP-1 transcription factors by antioxidant liposome Protein 3 3 Western blot analysis NM
784 CEES Exposure Lung Biopsy FOS UP Case-Control CEES Exposure CEES Exposure <0.05 in vivo Cavia porcellus Inhibition of CEES-induced increase in protein levels of AP-1 transcription factors by antioxidant liposome Protein 3 3 Western blot analysis NM
938 CEES Exposure Lung Biopsy JUN UP Case-Control Healthy Control CEES Exposure <0.05 in vivo Cavia porcellus Inhibition of CEES-induced increase in protein levels of AP-1 transcription factors by antioxidant liposome Protein 3 3 Western blot analysis NM
939 CEES Exposure Lung Biopsy JUN DOWN Case-Control CEES Exposure CEES Exposure <0.05 in vivo Cavia porcellus Inhibition of CEES-induced increase in protein levels of AP-1 transcription factors by antioxidant liposome Protein 3 3 Western blot analysis NM
940 CEES Exposure Lung Biopsy JUN UP Case-Control Healthy Control CEES Exposure <0.05 in vivo Cavia porcellus Inhibition of CEES-induced increase in protein levels of AP-1 transcription factors by antioxidant liposome Protein 3 3 Western blot analysis NM
941 CEES Exposure Lung Biopsy JUN DOWN Case-Control CEES Exposure CEES Exposure <0.05 in vivo Cavia porcellus Inhibition of CEES-induced increase in protein levels of AP-1 transcription factors by antioxidant liposome Protein 3 3 Western blot analysis NM
961 CEES Exposure Lung Biopsy CCND1 UP Case-Control Healthy Control CEES Exposure <0.05 in vivo Cavia porcellus Protection against CEES-induced increase in AP-1-dependent cell cycle proteins by antioxidant liposome Protein 3 3 Western blot analysis NM
1105 CEES Exposure Lung Biopsy CCND1 DOWN Case-Control CEES Exposure CEES Exposure <0.05 in vivo Cavia porcellus Protection against CEES-induced increase in AP-1-dependent cell cycle proteins by antioxidant liposome Protein 3 3 Western blot analysis NM
1328 CEES Exposure Lung Biopsy CCND1 UP Case-Control Healthy Control CEES Exposure <0.05 in vivo Cavia porcellus Protection against CEES-induced increase in AP-1-dependent cell cycle proteins by antioxidant liposome Protein 3 3 Western blot analysis NM
1329 CEES Exposure Lung Biopsy CCND1 UP Case-Control CEES Exposure CEES Exposure <0.05 in vivo Cavia porcellus Protection against CEES-induced increase in AP-1-dependent cell cycle proteins by antioxidant liposome Protein 3 3 Western blot analysis NM
1330 CEES Exposure Lung Biopsy JUNB UP Case-Control Healthy Control CEES Exposure <0.05 in vivo Cavia porcellus Inhibition of CEES-induced increase in protein levels of AP-1 transcription factors by antioxidant liposome Protein 3 3 Western blot analysis NM
1331 CEES Exposure Lung Biopsy JUNB DOWN Case-Control CEES Exposure CEES Exposure <0.05 in vivo Cavia porcellus Inhibition of CEES-induced increase in protein levels of AP-1 transcription factors by antioxidant liposome Protein 3 3 Western blot analysis NM
1332 CEES Exposure Lung Biopsy JUNB UP Case-Control Healthy Control CEES Exposure <0.05 in vivo Cavia porcellus Inhibition of CEES-induced increase in protein levels of AP-1 transcription factors by antioxidant liposome Protein 3 3 Western blot analysis NM
1333 CEES Exposure Lung Biopsy JUNB DOWN Case-Control CEES Exposure CEES Exposure <0.05 in vivo Cavia porcellus Inhibition of CEES-induced increase in protein levels of AP-1 transcription factors by antioxidant liposome Protein 3 3 Western blot analysis NM
1334 CEES Exposure Lung Biopsy JUND UP Case-Control Healthy Control CEES Exposure <0.05 in vivo Cavia porcellus Inhibition of CEES-induced increase in protein levels of AP-1 transcription factors by antioxidant liposome Protein 3 3 Western blot analysis NM
1335 CEES Exposure Lung Biopsy JUND DOWN Case-Control CEES Exposure CEES Exposure <0.05 in vivo Cavia porcellus Inhibition of CEES-induced increase in protein levels of AP-1 transcription factors by antioxidant liposome Protein 3 3 Western blot analysis NM
1338 CEES Exposure Lung Biopsy JUND UP Case-Control Healthy Control CEES Exposure <0.05 in vivo Cavia porcellus Inhibition of CEES-induced increase in protein levels of AP-1 transcription factors by antioxidant liposome Protein 3 3 Western blot analysis NM
1424 CEES Exposure Lung Biopsy JUND UP Case-Control CEES Exposure CEES Exposure <0.05 in vivo Cavia porcellus Inhibition of CEES-induced increase in protein levels of AP-1 transcription factors by antioxidant liposome Protein 3 3 Western blot analysis NM
1425 CEES Exposure Lung Biopsy JUN UP Case-Control Healthy Control CEES Exposure <0.05 in vivo Cavia porcellus DNA Binding Activity of AP-1 family Protein 3 3 Enzyme-linked immunosorbent assay (ELISA) NM
1426 CEES Exposure Lung Biopsy JUN UP Case-Control CEES Exposure CEES Exposure <0.05 in vivo Cavia porcellus DNA Binding Activity of AP-1 family Protein 3 3 Enzyme-linked immunosorbent assay (ELISA) NM
1461 CEES Exposure Lung Biopsy JUN UP Case-Control Healthy Control CEES Exposure <0.05 in vivo Cavia porcellus DNA Binding Activity of AP-1 family Protein 3 3 Enzyme-linked immunosorbent assay (ELISA) NM
1462 CEES Exposure Lung Biopsy JUN DOWN Case-Control CEES Exposure CEES Exposure <0.05 in vivo Cavia porcellus DNA Binding Activity of AP-1 family Protein 3 3 Enzyme-linked immunosorbent assay (ELISA) NM
1463 CEES Exposure Lung Biopsy PCNA UP Case-Control Healthy Control CEES Exposure <0.05 in vivo Cavia porcellus Protection against CEES-induced increase in AP-1-dependent cell cycle proteins by antioxidant liposome Protein 3 3 Western blot analysis NM
1464 CEES Exposure Lung Biopsy PCNA UP Case-Control CEES Exposure CEES Exposure <0.05 in vivo Cavia porcellus Protection against CEES-induced increase in AP-1-dependent cell cycle proteins by antioxidant liposome Protein 3 3 Western blot analysis NM
1465 CEES Exposure Lung Biopsy PCNA UP Case-Control Healthy Control CEES Exposure <0.05 in vivo Cavia porcellus Protection against CEES-induced increase in AP-1-dependent cell cycle proteins by antioxidant liposome Protein 3 3 Western blot analysis NM
1542 CEES Exposure Lung Biopsy PCNA DOWN Case-Control CEES Exposure CEES Exposure <0.05 in vivo Cavia porcellus Protection against CEES-induced increase in AP-1-dependent cell cycle proteins by antioxidant liposome Protein 3 3 Western blot analysis NM
1543 CEES Exposure Lung Biopsy TNF UP Case-Control Healthy Control CEES Exposure <0.05 in vivo Cavia porcellus Attenuation of CEES-induced activation of TNF- by antioxidant liposome Protein 3 3 Enzyme-linked immunosorbent assay (ELISA) NM
1544 CEES Exposure Lung Biopsy TNF UP Case-Control CEES Exposure CEES Exposure <0.05 in vivo Cavia porcellus Attenuation of CEES-induced activation of TNF- by antioxidant liposome Protein 3 3 Enzyme-linked immunosorbent assay (ELISA) NM
1545 CEES Exposure Lung Biopsy TNF UP Case-Control Healthy Control CEES Exposure <0.05 in vivo Cavia porcellus Attenuation of CEES-induced activation of TNF- by antioxidant liposome Protein 3 3 Enzyme-linked immunosorbent assay (ELISA) NM
1546 CEES Exposure Lung Biopsy TNF UP Case-Control CEES Exposure CEES Exposure <0.05 in vivo Cavia porcellus Attenuation of CEES-induced activation of TNF- by antioxidant liposome Protein 3 3 Enzyme-linked immunosorbent assay (ELISA) NM
1547 CEES Exposure Lung Biopsy FOSB UP Case-Control Healthy Control CEES Exposure <0.05 in vivo Cavia porcellus DNA Binding Activity of AP-1 family Protein 3 3 Enzyme-linked immunosorbent assay (ELISA) NM
1548 CEES Exposure Lung Biopsy FOSB DOWN Case-Control CEES Exposure CEES Exposure <0.05 in vivo Cavia porcellus DNA Binding Activity of AP-1 family Protein 3 3 Enzyme-linked immunosorbent assay (ELISA) NM
1549 CEES Exposure Lung Biopsy FOSB UP Case-Control Healthy Control CEES Exposure <0.05 in vivo Cavia porcellus DNA Binding Activity of AP-1 family Protein 3 3 Enzyme-linked immunosorbent assay (ELISA) NM
1550 CEES Exposure Lung Biopsy FOSB DOWN Case-Control CEES Exposure CEES Exposure <0.05 in vivo Cavia porcellus DNA Binding Activity of AP-1 family Protein 3 3 Enzyme-linked immunosorbent assay (ELISA) NM
1551 CEES Exposure Lung Biopsy JUNB UP Case-Control Healthy Control CEES Exposure <0.05 in vivo Cavia porcellus DNA Binding Activity of AP-1 family Protein 3 3 Enzyme-linked immunosorbent assay (ELISA) NM
1552 CEES Exposure Lung Biopsy JUNB NC Case-Control CEES Exposure CEES Exposure <0.05 in vivo Cavia porcellus DNA Binding Activity of AP-1 family Protein 3 3 Enzyme-linked immunosorbent assay (ELISA) NM
1553 CEES Exposure Lung Biopsy JUNB NC Case-Control Healthy Control CEES Exposure <0.05 in vivo Cavia porcellus DNA Binding Activity of AP-1 family Protein 3 3 Enzyme-linked immunosorbent assay (ELISA) NM
1591 CEES Exposure Lung Biopsy JUNB NC Case-Control CEES Exposure CEES Exposure <0.05 in vivo Cavia porcellus DNA Binding Activity of AP-1 family Protein 3 3 Enzyme-linked immunosorbent assay (ELISA) NM
1592 CEES Exposure Lung Biopsy JUND UP Case-Control Healthy Control CEES Exposure <0.05 in vivo Cavia porcellus DNA Binding Activity of AP-1 family Protein 3 3 Enzyme-linked immunosorbent assay (ELISA) NM
1593 CEES Exposure Lung Biopsy JUND UP Case-Control CEES Exposure CEES Exposure <0.05 in vivo Cavia porcellus DNA Binding Activity of AP-1 family Protein 3 3 Enzyme-linked immunosorbent assay (ELISA) NM
1594 CEES Exposure Lung Biopsy JUND UP Case-Control Healthy Control CEES Exposure <0.05 in vivo Cavia porcellus DNA Binding Activity of AP-1 family Protein 3 3 Enzyme-linked immunosorbent assay (ELISA) NM
1645 CEES Exposure Lung Biopsy JUND DOWN Case-Control CEES Exposure CEES Exposure <0.05 in vivo Cavia porcellus DNA Binding Activity of AP-1 family Protein 3 3 Enzyme-linked immunosorbent assay (ELISA) NM
1823 CEES Exposure Lung Biopsy MAPK1/ACTB ratio UP Case-Control Healthy Control CEES Exposure <0.05 in vivo Cavia porcellus Effects of antioxidant liposome on CEES-induced changes in MAPKs Protein 3 3 Western blot analysis NM
1871 CEES Exposure Lung Biopsy MAPK1/ACTB ratio DOWN Case-Control CEES Exposure CEES Exposure <0.05 in vivo Cavia porcellus Effects of antioxidant liposome on CEES-induced changes in MAPKs Protein 3 3 Western blot analysis NM
1872 CEES Exposure Lung Biopsy MAPK1/ACTB ratio NC Case-Control Healthy Control CEES Exposure <0.05 in vivo Cavia porcellus Effects of antioxidant liposome on CEES-induced changes in MAPKs Protein 3 3 Western blot analysis NM
1873 CEES Exposure Lung Biopsy MAPK1/ACTB ratio DOWN Case-Control CEES Exposure CEES Exposure <0.05 in vivo Cavia porcellus Effects of antioxidant liposome on CEES-induced changes in MAPKs Protein 3 3 Western blot analysis NM
1874 CEES Exposure Lung Biopsy MAPK14/ACTB ratio UP Case-Control Healthy Control CEES Exposure <0.05 in vivo Cavia porcellus Effects of antioxidant liposome on CEES-induced changes in MAPKs Protein 3 3 Western blot analysis NM
1921 CEES Exposure Lung Biopsy MAPK14/ACTB ratio DOWN Case-Control CEES Exposure CEES Exposure <0.05 in vivo Cavia porcellus Effects of antioxidant liposome on CEES-induced changes in MAPKs Protein 3 3 Western blot analysis NM
1922 CEES Exposure Lung Biopsy MAPK14/ACTB ratio DOWN Case-Control Healthy Control CEES Exposure <0.05 in vivo Cavia porcellus Effects of antioxidant liposome on CEES-induced changes in MAPKs Protein 3 3 Western blot analysis NM
1923 CEES Exposure Lung Biopsy MAPK14/ACTB ratio DOWN Case-Control CEES Exposure CEES Exposure <0.05 in vivo Cavia porcellus Effects of antioxidant liposome on CEES-induced changes in MAPKs Protein 3 3 Western blot analysis NM
2229 CEES Exposure Lung Biopsy MAPK8/ACTB ratio NC Case-Control Healthy Control CEES Exposure <0.05 in vivo Cavia porcellus Effects of antioxidant liposome on CEES-induced changes in MAPKs Protein 3 3 Western blot analysis NM
2230 CEES Exposure Lung Biopsy MAPK8/ACTB ratio NC Case-Control CEES Exposure CEES Exposure <0.05 in vivo Cavia porcellus Effects of antioxidant liposome on CEES-induced changes in MAPKs Protein 3 3 Western blot analysis NM
2231 CEES Exposure Lung Biopsy MAPK8/ACTB ratio NC Case-Control Healthy Control CEES Exposure <0.05 in vivo Cavia porcellus Effects of antioxidant liposome on CEES-induced changes in MAPKs Protein 3 3 Western blot analysis NM
2232 CEES Exposure Lung Biopsy MAPK8/ACTB ratio NC Case-Control CEES Exposure CEES Exposure <0.05 in vivo Cavia porcellus Effects of antioxidant liposome on CEES-induced changes in MAPKs Protein 3 3 Western blot analysis NM
2233 CEES Exposure Lung Biopsy FOS UP Case-Control Healthy Control CEES Exposure <0.05 in vivo Cavia porcellus Protein 3 3 Enzyme-linked immunosorbent assay (ELISA) NM
2234 CEES Exposure Lung Biopsy FOS NC Case-Control Healthy Control CEES Exposure <0.05 in vivo Cavia porcellus Protein 3 3 Enzyme-linked immunosorbent assay (ELISA) NM
2235 CEES Exposure Lung Biopsy FOS NC Case-Control Healthy Control CEES Exposure <0.05 in vivo Cavia porcellus Protein 3 3 Enzyme-linked immunosorbent assay (ELISA) NM
2236 CEES Exposure Lung Biopsy FOS NC Case-Control Healthy Control CEES Exposure <0.05 in vivo Cavia porcellus Protein 3 3 Enzyme-linked immunosorbent assay (ELISA) NM
2242 CEES Exposure Lung Biopsy FOS NC Case-Control Healthy Control CEES Exposure <0.05 in vivo Cavia porcellus Protein 3 3 Enzyme-linked immunosorbent assay (ELISA) NM
2243 CEES Exposure Lung Biopsy FOS UP Case-Control Healthy Control CEES Exposure <0.05 in vivo Cavia porcellus Protein 3 3 Enzyme-linked immunosorbent assay (ELISA) NM
2261 CEES Exposure Lung Biopsy FOS NC Case-Control Healthy Control CEES Exposure <0.05 in vivo Cavia porcellus Protein 3 3 Enzyme-linked immunosorbent assay (ELISA) NM
2262 CEES Exposure Lung Biopsy FOS NC Case-Control Healthy Control CEES Exposure <0.05 in vivo Cavia porcellus Protein 3 3 Enzyme-linked immunosorbent assay (ELISA) NM
2263 CEES Exposure Lung Biopsy JUN UP Case-Control Healthy Control CEES Exposure <0.05 in vivo Cavia porcellus Protein 3 3 Enzyme-linked immunosorbent assay (ELISA) NM
2264 CEES Exposure Lung Biopsy JUN NC Case-Control Healthy Control CEES Exposure <0.05 in vivo Cavia porcellus Protein 3 3 Enzyme-linked immunosorbent assay (ELISA) NM
2265 CEES Exposure Lung Biopsy JUN UP Case-Control Healthy Control CEES Exposure <0.05 in vivo Cavia porcellus Protein 3 3 Enzyme-linked immunosorbent assay (ELISA) NM
2266 CEES Exposure Lung Biopsy JUN NC Case-Control Healthy Control CEES Exposure <0.05 in vivo Cavia porcellus Protein 3 3 Enzyme-linked immunosorbent assay (ELISA) NM
2267 CEES Exposure Lung Biopsy JUN NC Case-Control Healthy Control CEES Exposure <0.05 in vivo Cavia porcellus Protein 3 3 Enzyme-linked immunosorbent assay (ELISA) NM
2268 CEES Exposure Lung Biopsy JUN UP Case-Control Healthy Control CEES Exposure <0.05 in vivo Cavia porcellus Protein 3 3 Enzyme-linked immunosorbent assay (ELISA) NM
2269 CEES Exposure Lung Biopsy JUN UP Case-Control Healthy Control CEES Exposure <0.05 in vivo Cavia porcellus Protein 3 3 Enzyme-linked immunosorbent assay (ELISA) NM
2270 CEES Exposure Lung Biopsy JUN NC Case-Control Healthy Control CEES Exposure <0.05 in vivo Cavia porcellus Protein 3 3 Enzyme-linked immunosorbent assay (ELISA) NM
2271 CEES Exposure Lung Biopsy MAPK1 UP Case-Control Healthy Control CEES Exposure <0.05 in vivo Cavia porcellus Protein 3 3 Western blot analysis NM
2307 CEES Exposure Lung Biopsy MAPK14 UP Case-Control Healthy Control CEES Exposure <0.05 in vivo Cavia porcellus Protein 3 3 Western blot analysis NM
2312 CEES Exposure Lung Biopsy MAPK8 UP Case-Control Healthy Control CEES Exposure <0.05 in vivo Cavia porcellus Protein 3 3 Western blot analysis NM
2317 CEES Exposure Lung Biopsy FOSB UP Case-Control Healthy Control CEES Exposure <0.05 in vivo Cavia porcellus Protein 3 3 Enzyme-linked immunosorbent assay (ELISA) NM
2678 CEES Exposure Lung Biopsy FOSB NC Case-Control Healthy Control CEES Exposure <0.05 in vivo Cavia porcellus Protein 3 3 Enzyme-linked immunosorbent assay (ELISA) NM
2679 CEES Exposure Lung Biopsy FOSB NC Case-Control Healthy Control CEES Exposure <0.05 in vivo Cavia porcellus Protein 3 3 Enzyme-linked immunosorbent assay (ELISA) NM
2680 CEES Exposure Lung Biopsy FOSB NC Case-Control Healthy Control CEES Exposure <0.05 in vivo Cavia porcellus Protein 3 3 Enzyme-linked immunosorbent assay (ELISA) NM
2681 CEES Exposure Lung Biopsy FOSB NC Case-Control Healthy Control CEES Exposure <0.05 in vivo Cavia porcellus Protein 3 3 Enzyme-linked immunosorbent assay (ELISA) NM
2682 CEES Exposure Lung Biopsy JUNB NC Case-Control Healthy Control CEES Exposure <0.05 in vivo Cavia porcellus Protein 3 3 Enzyme-linked immunosorbent assay (ELISA) NM
2683 CEES Exposure Lung Biopsy JUNB NC Case-Control Healthy Control CEES Exposure <0.05 in vivo Cavia porcellus Protein 3 3 Enzyme-linked immunosorbent assay (ELISA) NM
2684 CEES Exposure Lung Biopsy JUNB NC Case-Control Healthy Control CEES Exposure <0.05 in vivo Cavia porcellus Protein 3 3 Enzyme-linked immunosorbent assay (ELISA) NM
2685 CEES Exposure Lung Biopsy JUNB NC Case-Control Healthy Control CEES Exposure <0.05 in vivo Cavia porcellus Protein 3 3 Enzyme-linked immunosorbent assay (ELISA) NM
2686 CEES Exposure Lung Biopsy JUNB NC Case-Control Healthy Control CEES Exposure <0.05 in vivo Cavia porcellus Protein 3 3 Enzyme-linked immunosorbent assay (ELISA) NM
2687 CEES Exposure Lung Biopsy JUND UP Case-Control Healthy Control CEES Exposure <0.05 in vivo Cavia porcellus Protein 3 3 Enzyme-linked immunosorbent assay (ELISA) NM
2688 CEES Exposure Lung Biopsy JUND NC Case-Control Healthy Control CEES Exposure <0.05 in vivo Cavia porcellus Protein 3 3 Enzyme-linked immunosorbent assay (ELISA) NM
2689 CEES Exposure Lung Biopsy JUND NC Case-Control Healthy Control CEES Exposure <0.05 in vivo Cavia porcellus Protein 3 3 Enzyme-linked immunosorbent assay (ELISA) NM
2690 CEES Exposure Lung Biopsy JUND NC Case-Control Healthy Control CEES Exposure <0.05 in vivo Cavia porcellus Protein 3 3 Enzyme-linked immunosorbent assay (ELISA) NM
2691 CEES Exposure Lung Biopsy JUND NC Case-Control Healthy Control CEES Exposure <0.05 in vivo Cavia porcellus Protein 3 3 Enzyme-linked immunosorbent assay (ELISA) NM
2692 CEES Exposure Lung Biopsy FOSB UP Case-Control Healthy Control CEES Exposure <0.05 in vivo Cavia porcellus Protein 3 3 Enzyme-linked immunosorbent assay (ELISA) NM
2693 CEES Exposure Lung Biopsy FOSB UP Case-Control Healthy Control CEES Exposure <0.05 in vivo Cavia porcellus Protein 3 3 Enzyme-linked immunosorbent assay (ELISA) NM
2694 CEES Exposure Lung Biopsy FOSB UP Case-Control Healthy Control CEES Exposure <0.05 in vivo Cavia porcellus Protein 3 3 Enzyme-linked immunosorbent assay (ELISA) NM
2695 CEES Exposure Lung Biopsy JUNB NC Case-Control Healthy Control CEES Exposure <0.05 in vivo Cavia porcellus Protein 3 3 Enzyme-linked immunosorbent assay (ELISA) NM
2696 CEES Exposure Lung Biopsy JUNB NC Case-Control Healthy Control CEES Exposure <0.05 in vivo Cavia porcellus Protein 3 3 Enzyme-linked immunosorbent assay (ELISA) NM
2697 CEES Exposure Lung Biopsy JUNB NC Case-Control Healthy Control CEES Exposure <0.05 in vivo Cavia porcellus Protein 3 3 Enzyme-linked immunosorbent assay (ELISA) NM
2698 CEES Exposure Lung Biopsy JUND UP Case-Control Healthy Control CEES Exposure <0.05 in vivo Cavia porcellus Protein 3 3 Enzyme-linked immunosorbent assay (ELISA) NM
2699 CEES Exposure Lung Biopsy JUND NC Case-Control Healthy Control CEES Exposure <0.05 in vivo Cavia porcellus Protein 3 3 Enzyme-linked immunosorbent assay (ELISA) NM
2700 CEES Exposure Lung Biopsy JUND NC Case-Control Healthy Control CEES Exposure <0.05 in vivo Cavia porcellus Protein 3 3 Enzyme-linked immunosorbent assay (ELISA) NM

© 2026 - Baqiyatallah University of Medical Sciences. All Rights Reserved